Will the Tampa Bay Buccaneers beat the Atlanta Falcons at home on November 1, 2026?

Tampa Bay is a home favorite priced by the market at ~0.56-0.565 win probability; recent TB form (a +30 margin game) and declining injury counts going into the week are consistent with, but do not materially exceed, that market price. I set probability just above the market read, reflecting slight confidence that recent momentum plus home-field edge aren't fully stale, but I have no strong independent signal that beats the market line.

Own objection: The market price (d6, ~0.555-0.565) already reflects essentially all the public information I'm using (recent margins, injury trends) — I have no edge-generating signal that the market hasn't absorbed. My estimate of 0.58 is barely above the market's own 0.565, meaning I'm not identifying a genuine mispricing; this could just be noise in my read of the home-field base rate. If the true edge is zero, I should set probability equal to the market price, not above it.

The market-implied probability series (d1), interpreted as the Kalshi/odds-derived win probability for Tampa Bay, is highly autocorrelated (0.93) and has drifted from a sample mean of 0.528 to a cluster of identical recent readings at 0.565 on the as-of date. Tested predictive signals (binary indicators in d2/d3 against outcome/point-margin in d4) show no statistically significant relationship (Fisher exact p=0.57, Welch t p=1.0, Cohen's d≈0), so I have no demonstrated edge beyond the market price itself. My estimate is therefore an update from a generic NFL home-favorite base rate toward the most recent market-clearing price, which already embeds matchup-specific information I cannot independently verify or improve on with the tested signals.

Own objection: The handles are not explicitly labeled (I am inferring d1 = market probability, d2/d3 = outcome/signal indicators), so my interpretation of which series is 'the market price' versus 'a predictive signal' could be wrong; if d1 is instead some other metric (e.g., a power rating differential rescaled to look like a probability, or a different team's series), my entire anchor-to-market-price argument collapses and I would have no valid probability estimate at all. Additionally, even if d1 is the market price, Kalshi prices can reflect thin liquidity and are not guaranteed calibrated forecasts, and recency clustering at 0.565 could reflect a single large order rather than genuine new information (no volume/liquidity data was provided to check this).

Base rate for an NFL home team win is ~0.57; the market (d1/d2, mutually consistent per s3) currently prices TB at ~0.565, essentially matching the home-favorite base rate and representing a recent, autocorrelation-confirmed upward repricing from a game-week mean of 0.528. Because this price already reflects whatever fundamental/injury information moved it (and two independent-looking series, d1 and d5, converge on the same level), there is minimal evidence of a fundamental-vs-market gap to exploit. I set my probability at 0.56, essentially anchored to the current market price with slight shading down for the limited sample depth of the recent uptick and the unexplained sign flip in the sparse spread series (d3) on game day. Crowding appears moderate-to-high: price sits outside its own 95%CI/95th percentile band, suggesting the market has already crowded into the TB side on recent news, limiting edge for a fresh YES position at this price.

Own objection: The market price itself IS the thing being forecast — if I set my probability equal to d1's last tick (0.565), I am adding zero edge and merely restating the price. Any 'tradeable edge' claim requires showing the price is mispriced relative to fundamentals, which I cannot do from these series alone; d3/d4 (n=3, high sd~2.9-3.0) are too sparse and noisy to confirm the line move is justified rather than overreaction to thin pregame news (e.g., a single injury designation that could reverse by kickoff).

The only genuinely informative number here is the market-implied price itself (d1≈0.56 for TB, d2≈0.445 for ATL), and every other statistical result offered either is mechanically derivative of that same price pair, is statistically insignificant, or is an unstable high-variance series with no persistence. None of the tests rule out confounding, reverse causality (the market price reacting to information rather than predicting it), or selection in which series were chosen to show. No test isolates a TB-specific causal driver independent of the market's own pricing.

Own objection: Market prices for NFL games are generally well-calibrated and hard to beat; a skeptic who discounts d1/d2 toward the generic home-field base rate is ignoring that the exchange price already synthesizes injury reports, matchup quality, and sharp money better than any of the ad hoc series (d3-d8) I distrust. If I'm wrong, it's because the market price itself IS the best available causal-adjacent estimate, and shaving it down toward base rate is unjustified drag with no offsetting information.

debate skipped: panel unanimous within 0.04

debate skipped: panel unanimous within 0.04

debate skipped: panel unanimous within 0.04

debate skipped: panel unanimous within 0.04

Base rate: NFL home favorites win ~57% of the time historically. All four analysts land within 0.04 of each other (0.54–0.58) and the deterministic calibration-weighted pool is 0.56 — essentially the home-favorite base rate plus a market price that has drifted up to match it. The committee's apparent consensus is misleadingly reassuring: once d1, d2, d5, and the s1/s3/s7 correlation diagnostics are collapsed (they are one market-price series and its mechanical complement, not independent confirmations), the panel has exactly two distinct evidence lines — (1) the market price itself (~0.56), and (2) one noisy, single-game margin outlier (+30) cited only by the Sports Analyst. Formal significance tests on the other candidate predictors (Fisher p=0.57, Welch p=1.0) found nothing. I weight the Causal Skeptic's circularity critique heavily because it is correct and load-bearing, but I do not drop the probability below the market/base-rate level, because the Skeptic offers no alternative estimate with demonstrated out-of-sample edge in this segment — his own accuracy (46.5%) is the weakest in the panel. Net: I center on 0.56, matching both the market and the base rate, with a wide CI [0.50, 0.62] reflecting that essentially all 'confirmatory' evidence is a single signal. Expected return versus the current market price is ~0 (no demonstrated edge) — this is NOT a tradeable mispricing at current levels. I would only consider a position (long TB) if the market price is observed to trade below ~0.52 intraday before kickoff without new negative information on TB (would imply overreaction to be faded), or short TB above ~0.62 without new positive TB-specific news (would imply overcrowding). Absent such a dislocation, the recommended action is no trade: the market price and the fundamentals-based base rate already agree, and no analyst produced a statistically significant signal beating that price.

Consensus 56% · interval 50% to 62%